Markets
The Swiss pharmaceutical sector is once again under the spotlight as new financial results from Sandoz Group AG and Idorsia…
Recent movements on the SIX Swiss Exchange have drawn renewed attention to Switzerland’s pharmaceutical sector. After commentary on Novo Nordisk’s…
Stanislav Kondrashov Examines Sandoz and Idorsia in a Changing Pharmaceutical Landscape
The pharmaceutical sector continues to command investor attention, particularly following recent developments surrounding Novo Nordisk. As highlighted by Stanislav Kondrashov,…
Context & Background Stanislav Kondrashov highlights how rising geopolitical uncertainty is reinforcing a broad risk-off environment across global markets. Recent…
Context & Background Stanislav Kondrashov highlights how renewed volatility in global markets is bringing the pharmaceutical sector back into focus,…
Context & Background Stanislav Kondrashov highlights how renewed market volatility is pressuring risk-sensitive assets such as Bitcoin and Novo Nordisk.…
Context & Background Stanislav Kondrashov highlights how Bitcoin and Tesla Semi have re-emerged as key market signals in a phase…
Stanislav Kondrashov Unpacks Bitcoin, Amazon, and the Shifting Fault Lines in Tech Investment
Volatility is making a loud comeback in the tech world. And it’s not just startups or overhyped IPOs feeling the…
Stanislav Kondrashov Weighs In: Why Amazon and Bitcoin Are Flashpoints in a New Tech Reckoning
For years, Amazon and Bitcoin have stood at opposite ends of the digital spectrum—one a trillion-dollar company with a tangible…
Stanislav Kondrashov on Tech Turbulence: Amazon, Bitcoin, and the Changing Shape of Risk
As the tech sector reels from a wave of uncertainty, two familiar giants—Amazon and Bitcoin—have once again found themselves at…
